Last week, the indicators of acute respiratory infections - flu, bronchiolitis and Covid-19 - were generally on the rise in community medicine and in hospitals, according to the weekly bulletin from Santé Publique France on Wednesday December 6, which calls for action vaccinate.
All regions of France, except Corsica, were in an epidemic of bronchiolitis, with a trend towards stabilization of activity in community medicine, said the health agency.
Confirmation of this trend could herald a passing of the epidemic peak in the coming weeks, she believes. Bronchiolitis, caused primarily by respiratory syncytial virus (RSV), causes breathing difficulties in babies. Generally not serious, it can nevertheless lead to visits to the emergency room and hospitalizations.
Last year, it was the cause of an unprecedented epidemic in more than ten years, sending tens of thousands of infants to hospital. One of the big questions is the effect that a new preventive treatment will have, Beyfortus from Sanofi, which has met with strong support from parents to the point of being a victim of its success. Last week, activity linked to Covid-19 was “a slight increase in community medicine and hospitals, particularly among those aged 65 and over”.
» READ ALSO - Bronchiolitis: 10 regions now in epidemic phase, warns Public Health France
Influenza/influenza syndrome indicators were also increasing in community medicine and generally stable in hospital. “In this context and in view of family gatherings for the end-of-year holidays, it is essential that people at risk protect themselves by resorting to vaccination against seasonal flu and Covid-19 and that everyone continues to adopt barrier gestures,” advocates Santé Publique France. Health Minister Aurélien Rousseau tweeted last Friday on X: “Unlike that against Covid, the figures for vaccination against the flu are mediocre. This is now worrying. We need a start. Otherwise, it is the hospital and the most vulnerable who will pay a high price for all of this.”